By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
Aa
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: Sunderstorm Introduces First-of-Its-Kind Scientifically-Backed Personal Dosing with NANO5 DNA
Share
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > Cannabis Press Releases > Sunderstorm Introduces First-of-Its-Kind Scientifically-Backed Personal Dosing with NANO5 DNA
Cannabis Press Releases

Sunderstorm Introduces First-of-Its-Kind Scientifically-Backed Personal Dosing with NANO5 DNA

Business Wire
Business Wire July 25, 2021
Updated 2022/05/30 at 7:56 AM
Share
SHARE

LOS ANGELES, July 22, 2021 /PRNewswire/ — Sunderstorm Inc., one of the cannabis industry’s leading consumer packaged goods companies, creators of California-based edible brand Kanha and nanomolecular sublingual brand NANO5, today introduced NANO5 DNA, a premium line of sublingual products scientifically tailored to match a consumer’s unique DNA. The product taps into the next big breakthrough in cannabis science by leveraging a simple, powerful truth: Cannabis Is Personal.


(PRNewsfoto/Sunderstorm)

- Advertisement -

Getting the ideal experience from cannabis is more than just choosing the right strain. Everyone experiences cannabis products differently based on their own unique endocannabinoid system. For some, the active compounds in the plant exert relaxing, calming effects. For others, cannabis can be a stimulant or in some instances cause anxiety. NANO5 DNA is the first THC product to scientifically align with a consumer’s unique genetic makeup to maximize the ability to enjoy an ideal experience with cannabis.

“Consumers often try multiple products in order to get the right effect. Genetically aligned cannabinoid formulations like NANO5 DNA match consumers with better experiences and outcomes from the first use,” said Len May, CEO and Co-Founder of EndoCanna Health. “We are proud to partner with Sunderstorm who is working at the forefront of personalized cannabis products.”

To personalize the process of selecting an ideal cannabis product, Sunderstorm partnered with EndoCanna Health, the creator of the patented EndoDNA Test. Leveraging the latest advances in the DNA testing industry, the EndoDNA test analyzes more than 700k SNPs (Single Nucleotide Polymorphisms) that are specific to or associate with the endocannabinoid system. Upon analyzing a consumer’s DNA, EndoCanna Health issues a secure, in-depth report that identifies their unique genotype, maps potential risks and positive outcomes, and aligns their DNA with the latest research to predict how they will respond to specific cannabinoids and terpenes. Then, EndoCanna Health matches them to the ideal NANO5 DNA formulation.

At launch, the new line of NANO5 DNA tinctures includes Relief, Unwind, and Response. Each contains specific CBD-to-THC ratios, tailor-fit terpene profiles, and select essential oils that are all offered in consistent concentrations with each dose. Combined with the grab-and-go simplicity and rapid effect onset of NANO5’s sublingual technology, NANO5 DNA offers genetically aligned product solutions that provide consumers with a reliable and repeatable positive cannabis experience.

“We have worked diligently with EndoCanna to develop the science, technology and delivery platform that will allow consumers to understand which cannabis formulations are optimized for their bodies,” said Cameron Clarke, Co-Founder and CEO of Sunderstorm. “NANO5 DNA’s cutting-edge scientific technology showcases not only the sophistication of cannabis consumer science, but also how CPG companies in the space are leveraging mainstream scientific methods to reinforce the industry’s overall legitimacy.”

At launch, NANO5 DNA is available only in California through select dispensaries and delivery services, including Mother Nature’s Remedy and Rebud Delivery.

- Advertisement -

About Sunderstorm

Established in 2015, Sunderstorm has emerged as one of the largest and most trusted manufacturers of cannabis products in California. With a mission to help people achieve a life of harmony and wellness with all-natural, consciously made, science-based cannabis products, Sunderstorm produces a wide assortment of edibles, sublinguals and vape cartridges. Widely considered the best tasting gummy in the industry, Sunderstorm’s Kanha premium gummies are made with the highest quality cannabis oils, scientifically extracted and infused to provide a consistent dose.

About EndoCanna Health™, Inc.

EndoCanna is a biotechnology research company that utilizes a patented process for its EndoDNA™ genetic test and product matching algorithm, EndoAligned™. EndoDNA™ provides two ways to submit DNA for analysis, either collected through a simple saliva swab or a direct upload of genetic data files from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. EndoCanna’s HIPAA compliant and secure health and wellness portal, Mydna.live, provides customers with a personalized experience where they can access their EndoDecoded report and EndoAligned formulation suggestions for their specific genotype.

For more information visit EndoDNA.com, contact:

Len May, CEO EndoCanna Health, Inc.

[email protected]

Media Contact

MATTIO Communications

[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sunderstorm-introduces-first-of-its-kind-scientifically-backed-personal-dosing-with-nano5-dna-301339104.html

SOURCE Sunderstorm

rt Cannabis Media & PR
source

You Might Also Like

Proposed Settlement Reached in 2016 Class Action

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

IIPR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. and Encourages Investors to Contact the Firm

Creators of Muscle Milk Launch New Hemp Infused Sports Nutrition Brand GYM WEED in U.S. Market

TAGGED: Cannabis, cannabis news, marijuana news, press release

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[wpforms id="4115329"]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Business Wire July 25, 2021
Share this Article
Twitter Reddit Email Copy Link
Previous Article Gage Growth Corp. Adds Two Retail Locations to Portfolio and Eleventh Contract Grower
Next Article Forian Inc. to Announce 2021 Second Quarter Results on August 12, 2021

You Might Also Like

Proposed Settlement Reached in 2016 Class Action

June 24, 2022

Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting

June 24, 2022

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

June 23, 2022

IIPR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Innovative Industrial Properties, Inc. and Encourages Investors to Contact the Firm

June 23, 2022

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?